216 related articles for article (PubMed ID: 33370049)
1. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
DeCoster RC; Clemens MW; Di Napoli A; Lynch EB; Bonaroti AR; Rinker BD; Butterfield TA; Vasconez HC
Plast Reconstr Surg; 2021 Jan; 147(1):30e-41e. PubMed ID: 33370049
[TBL] [Abstract][Full Text] [Related]
2. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
3. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
[TBL] [Abstract][Full Text] [Related]
4. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
[TBL] [Abstract][Full Text] [Related]
5. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
[TBL] [Abstract][Full Text] [Related]
6. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Kadin ME
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
[TBL] [Abstract][Full Text] [Related]
7. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
8. Biological and genetic landscape of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
Rondón-Lagos M; Rangel N; Camargo-Villalba G; Forero-Castro M
Eur J Surg Oncol; 2021 May; 47(5):942-951. PubMed ID: 33158639
[TBL] [Abstract][Full Text] [Related]
9. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
10. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
11. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Oishi N; Miranda RN; Feldman AL
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
[TBL] [Abstract][Full Text] [Related]
12. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
13. New insights into breast implant-associated anaplastic large cell lymphoma.
Laurent C; Haioun C; Brousset P; Gaulard P
Curr Opin Oncol; 2018 Sep; 30(5):292-300. PubMed ID: 30096095
[TBL] [Abstract][Full Text] [Related]
14. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
15. Breast Implant-associated Anaplastic Large Cell Lymphoma.
Alotaibi S; Hamadani M; Al-Mansour M; Aljurf M
Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e272-e276. PubMed ID: 33384263
[TBL] [Abstract][Full Text] [Related]
16. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.
Tabanelli V; Corsini C; Fiori S; Agostinelli C; Calleri A; Orecchioni S; Melle F; Motta G; Rotili A; Di Napoli A; Pileri SA
Hum Pathol; 2019 Aug; 90():60-69. PubMed ID: 31125630
[TBL] [Abstract][Full Text] [Related]
17. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
18. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
19. The Crucial Role of Surgical Treatment in BIA-ALCL Prognosis in Early- and Advanced-Stage Patients.
Campanale A; Spagnoli A; Lispi L; Boldrini R; Marletta M
Plast Reconstr Surg; 2020 Nov; 146(5):530e-538e. PubMed ID: 32852469
[TBL] [Abstract][Full Text] [Related]
20. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]